Sadar MD - Search Results

1

Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions.

Le L, Chi K, Tyldesley S, Flibotte S, Diamond DL, Kuzyk MA, Sadar MD. Le L, et al. Among authors: sadar md. Clin Chem. 2005 Apr;51(4):695-707. doi: 10.1373/clinchem.2004.041087. Epub 2005 Feb 3. Clin Chem. 2005. PMID: 15695329

2

Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis.

Cheung PK, Woolcock B, Adomat H, Sutcliffe M, Bainbridge TC, Jones EC, Webber D, Kinahan T, Sadar M, Gleave ME, Vielkind J. Cheung PK, et al. Cancer Res. 2004 Sep 1;64(17):5929-33. doi: 10.1158/0008-5472.CAN-04-1216. Cancer Res. 2004. PMID: 15342369

3

Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

Sobel RE, Sadar MD. Sobel RE, et al. Among authors: sadar md. J Urol. 2005 Feb;173(2):342-59. doi: 10.1097/01.ju.0000141580.30910.57. J Urol. 2005. PMID: 15643172 Review.

4

Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.

Yee J, Sadar MD, Sin DD, Kuzyk M, Xing L, Kondra J, McWilliams A, Man SF, Lam S. Yee J, et al. Among authors: sadar md. J Clin Oncol. 2009 Jun 10;27(17):2787-92. doi: 10.1200/JCO.2008.19.4233. Epub 2009 May 4. J Clin Oncol. 2009. PMID: 19414677 Free PMC article.

5

Revealing Metabolic Liabilities of Ralaniten To Enhance Novel Androgen Receptor Targeted Therapies.

Obst JK, Wang J, Jian K, Williams DE, Tien AH, Mawji N, Tam T, Yang YC, Andersen RJ, Chi KN, Montgomery B, Sadar MD. Obst JK, et al. Among authors: sadar md. ACS Pharmacol Transl Sci. 2019 Sep 26;2(6):453-467. doi: 10.1021/acsptsci.9b00065. eCollection 2019 Dec 13. ACS Pharmacol Transl Sci. 2019. PMID: 32259077 Free PMC article.

6

Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP.

Sato N, Sadar MD, Bruchovsky N, Saatcioglu F, Rennie PS, Sato S, Lange PH, Gleave ME. Sato N, et al. Among authors: sadar md. J Biol Chem. 1997 Jul 11;272(28):17485-94. doi: 10.1074/jbc.272.28.17485. J Biol Chem. 1997. PMID: 9211894 Free article.

7

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways.

Ueda T, Bruchovsky N, Sadar MD. Ueda T, et al. Among authors: sadar md. J Biol Chem. 2002 Mar 1;277(9):7076-85. doi: 10.1074/jbc.M108255200. Epub 2001 Dec 19. J Biol Chem. 2002. PMID: 11751884 Free article.

8

Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells.

Ueda T, Mawji NR, Bruchovsky N, Sadar MD. Ueda T, et al. Among authors: sadar md. J Biol Chem. 2002 Oct 11;277(41):38087-94. doi: 10.1074/jbc.M203313200. Epub 2002 Aug 5. J Biol Chem. 2002. PMID: 12163482 Free article.

9

Androgens and androgen receptor in prostate and ovarian malignancies.

Meehan KL, Sadar MD. Meehan KL, et al. Among authors: sadar md. Front Biosci. 2003 May 1;8:d780-800. doi: 10.2741/1063. Front Biosci. 2003. PMID: 12700055 Review.

10

Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells.

Blaszczyk N, Masri BA, Mawji NR, Ueda T, McAlinden G, Duncan CP, Bruchovsky N, Schweikert HU, Schnabel D, Jones EC, Sadar MD. Blaszczyk N, et al. Among authors: sadar md. Clin Cancer Res. 2004 Mar 1;10(5):1860-9. doi: 10.1158/1078-0432.ccr-0974-3. Clin Cancer Res. 2004. PMID: 15014041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters